Oramed Pharmaceuticals Inc. ("Oramed" or the "Company" or "we"), a clinical-stage pharmaceutical company, today issued a Letter to Shareholders from its President and Chief Executive Officer, Nadav ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback